Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The digestive supplements market was valued at USD 10.83 Billion in 2025 and is expected to grow at a CAGR of 6.20%, reaching USD 19.76 Billion by 2035. The market growth is driven by the rising gut health awareness and preventive wellness adoption. The benefits from expanding probiotic innovations and functional nutrition demand. The forecast period shows increased demand across global healthcare applications.
Compound Annual Growth Rate
6.2%
Value in USD Billion
2026-2035
Digestive supplements are dietary products designed to support and enhance the body’s natural digestive processes. They often contain enzymes, probiotics, prebiotics, or herbal ingredients that aid in breaking down food, improving nutrient absorption, and promoting gut health. These supplements can help alleviate symptoms like bloating, indigestion, and constipation. Commonly used by individuals with digestive disorders or dietary imbalances, they contribute to overall gastrointestinal wellness and better digestive function. The market is expected to grow at a CAGR of 6.20% during the forecast period of 2026-2035 and attain a market value of USD 19.76 Billion by 2035.
Expanding Product Portfolios Driving Market Growth
Rising consumer awareness of gut health and increasing demand for scientifically backed digestive supplements are key market drivers. For instance, in March 2025, Nature Made, a leading vitamin and supplement brand with over 50 years of expertise, launched new clinically studied probiotic, prebiotic, and fiber formulations targeting daily gut health. These innovations cater to specific wellness needs, enhancing consumer trust. This product expansion is poised to fuel market growth by addressing diverse digestive health concerns during the forecast period.
Introduction of Novel Therapies in the Landscape Supporting Digestive Supplements Market Development
The growing prevalence of irritable bowel syndrome (IBS) and rising focus on effective treatments are crucial market drivers. For instance, in May 2025, Ardelyx, Inc., presented data on its FDA-approved IBS treatment, IBSRELA® (tenapanor), alongside findings from the IBS in America 2024 supplemental survey at the Digestive Disease Week Conference. This information highlights unmet digestive health needs, likely increasing consumer interest in complementary digestive supplements, thus positively influencing market development and growth over the forecast period.
BioGaia announced the launch of BioGaia® Colus®, a targeted probiotic formulation designed to support colon health. The product contains the proprietary Limosilactobacillus reuteri BG-R59® strain and uses delayed-release technology to deliver the probiotic farther into the gastrointestinal tract. BioGaia stated that the formulation is supported by two independent randomized, double-blind, placebo-controlled clinical studies. The launch reflects the industry's shift toward strain-specific digestive supplements designed for particular regions and functions of the gastrointestinal system rather than broad probiotic positioning.
Superbrewed Food commercially launched Thryvia™, a protein-derived postbiotic designed for digestive and immune health formulations. Unlike live probiotics, the non-viable ingredient does not require maintenance of microbial viability during manufacturing, distribution or shelf life. The company states that Thryvia can be incorporated into capsules, powders, gummies, bars, foods and beverages, including shelf-stable and UHT-processed products. At approximately 200 mg per serving, the ingredient provides formulators with a relatively low-inclusion postbiotic platform. The launch highlights increasing interest in alternatives to conventional live probiotic formats.
Bayer's Consumer Health division launched Alka-Seltzer® in India as an effervescent digestive-health product combining antacid action with probiotic support. Bayer described it as India's first AYUSH-category antacid with probiotic support and stated that the formulation contains Lactobacillus derived from curd extract. The product is supplied in single-use lemon-flavoured sachets and targets acidity, gas and indigestion. Bayer's launch materials cite consumer research indicating that nearly 7 in 10 urban Indian consumers experience digestive issues weekly or daily, while acidity, gas and indigestion were reported at 37%, 33% and 20%, respectively.
BioGaia launched BioGaia® Protectis® Plus, a dual-strain probiotic supplement for babies experiencing colic and digestive discomfort. The product combines the company's established Limosilactobacillus reuteri Protectis® strain with the newly patented L. reuteri BG-R46® strain. BioGaia stated that the original Protectis probiotic is supported by more than 30 years of probiotic research, while the new formulation is intended to provide additive probiotic effects. The launch demonstrates how digestive supplement manufacturers are increasingly developing formulations around specific life stages and targeted gastrointestinal needs rather than relying solely on broad adult gut-health products.
Digestive health is moving beyond a niche supplement category and becoming part of broader preventive wellness routines. A 2026 International Food Information Council survey found that 64% of Americans consider gut health a high or extremely high priority, with 48% identifying digestive comfort and 38% regular bowel movements among the outcomes most associated with gut health. This creates opportunities for supplements positioned around everyday digestive comfort rather than only specific gastrointestinal conditions. The shift is also reflected in broader supplement use- a 2025 analysis of nationally representative NHANES data found that overall dietary supplement use among US adults rose from 51.8% in 2011–12 to 61.4% in 2021–23.
Digestive supplement development is increasingly emphasizing the particular microorganism and strain used rather than treating all probiotics as interchangeable. Scientific guidance from the International Scientific Association for Probiotics and Prebiotics (ISAPP) states that probiotic products should identify microorganisms by genus, species and strain because benefits are associated with specific strains and demonstrated applications. Consumer interest is substantial in such a scenario. A 2025 YouGov survey found that 33% of US adults had bought or used probiotics or prebiotics during the previous year, making them the most commonly used category among the niche supplements examined. This is encouraging manufacturers to differentiate formulations through strain selection, clinical evidence, dosage and targeted digestive-health applications.
Postbiotics are emerging as an important alternative to supplements based exclusively on live microorganisms. ISAPP defines a postbiotic as a preparation of inanimate microorganisms or their components that provides a demonstrated health benefit. Unlike conventional probiotics, postbiotics do not require microorganisms to remain viable through storage and consumption, creating opportunities for more stable formulations and products exposed to challenging manufacturing conditions. Consumer awareness is also increasing- a 2024 Danone North America survey found that 60% of Americans were familiar with postbiotics, up 11 percentage points from 2021. At the same time, the scientific community stresses that simply using dead probiotic cells does not automatically make a product a postbiotic, efficacy must be demonstrated for the inactivated preparation.
Digestive supplements are increasingly combining microbial ingredients with substrates that support beneficial gut microorganisms. This is strengthening interest in prebiotics, fibre blends and synbiotic formulations alongside traditional probiotic capsules. NIQ's 2025 global health-and-wellness research found that 53% of consumers across 19 countries planned to purchase more high-fibre foods, while around 40% planned to buy more probiotic foods. Separately, a 2025 analysis of US NHANES data identified fibre and probiotics among the supplement categories showing increasing use over the 2011–2023 period. This convergence is encouraging manufacturers to formulate products around multiple mechanisms, such as providing beneficial microorganisms together with fermentable substrates, rather than relying on a single digestive-health ingredient.
The expansion of digestive-health products is occurring alongside significant gaps in consumer understanding, increasing the importance of clinically supported claims and transparent formulation information. The 2026 IFIC gut-health survey found that only 36% of Americans selected proper digestion and nutrient absorption when defining gut health, while consumers commonly associated it with immediate digestive outcomes. Earlier Danone North America research similarly found that 41% of Americans were unaware of the gut microbiome. These gaps create pressure on supplement brands to explain strains, doses, mechanisms and evidence more clearly. For manufacturers, clinical trials and precise ingredient labelling can therefore become important tools for distinguishing targeted digestive supplements from products making broad or poorly defined gut-health claims.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
Market Breakup by Form
Market Breakup by Source
Market Breakup by Application
Market Breakup by End User
Market Breakup by Distribution Channel
Market Breakup by Region
Tablets to Dominating the Segmentation by Form
Tablets are expected to hold the largest market share in the market due to their convenience, long shelf life, and cost-effectiveness in mass production. Their ease of storage, accurate dosing, and wide availability in pharmacies make them a preferred choice for both consumers and manufacturers. As digestive health awareness grows, especially among aging populations, the demand for simple, swallowable tablet forms is anticipated to drive market expansion during the forecast period.
North America leading the Segment due to Strong Clinical Focus
North America is projected to hold the largest market share in the digestive supplements market, fueled by high digestive disorder prevalence, especially in the United States, and increasing clinical recommendations for supplement use. The region’s strong nutraceutical infrastructure, rising probiotic product innovations, and growing geriatric population further accelerate demand. While Europe follows closely due to regulatory backing for gut health products, Asia-Pacific is rapidly emerging with expanding wellness trends and increasing supplement penetration across urbanizing regions.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
AdvaCare Pharma, established in 2000 and headquartered in the United States, is a global pharmaceutical and healthcare products company. It offers a wide range of digestive supplements, including probiotics, enzyme blends, and herbal-based formulations. The company operates across over 65 countries, focusing on affordable, GMP-compliant products, and supports both human and veterinary health with a strong emphasis on emerging markets.
Founded in 1957 and headquartered in Chino, California, Specialty Enzymes & Probiotics specializes in the research, development, and manufacturing of high-quality enzyme and probiotic supplements. The company serves various industries, including dietary supplements, pharmaceuticals, and functional foods. With in-house fermentation and formulation capabilities, it offers tailored digestive health solutions that are widely recognized for efficacy and innovation across global markets.
Aumenzymes, established in India, is a biotech company focused on enzyme-based solutions, especially in the digestive supplements space. Known for its expertise in fermentation and enzyme production, the company provides formulations targeting gut health, digestion, and overall wellness. Its portfolio includes enzyme blends for the food, nutraceutical, and pharmaceutical industries, emphasizing sustainable, non-GMO, and vegan-friendly products for global clients.
Established in 2004 and headquartered in Haridwar, India, Akums Drugs and Pharmaceuticals Ltd. is a leading contract manufacturing organization. It offers a diverse range of healthcare products, including digestive supplements such as probiotics, enzymes, and nutraceuticals. With multiple WHO-GMP-certified manufacturing facilities, Akums serves both domestic and international markets with high-quality, customized formulations across therapeutic categories.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include TopGum Industries Ltd., Haleon plc, Leeford Healthcare Limited, AB-BIOTICS, SA, Bayer AG, and Amway Group.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Form |
|
| Breakup by Source |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.